FBLG (STOCKS)
FibroBiologics, Inc. Common Stock
$1.400000
+0.050000 (+3.70%)
Prev close: $1.350000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Peter O'Heeron
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4.83M
- Employees
- 13
- P/E (TTM)
- -0.16
- P/B (TTM)
- 0.73
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$2.00M |
| Operating Expenses | $16.65M |
| Research and Development | $7.41M |
| Other Operating Expenses | $9.24M |
| Operating Income/Loss | -$16.65M |
| Income/Loss From Continuing Operations After Tax | -$18.65M |
| Income/Loss From Continuing Operations Before Tax | -$18.65M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$18.65M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$18.65M |
| Net Income/Loss Available To Common Stockholders, Basic | -$18.65M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.42 |
| Diluted Earnings Per Share | -$0.42 |
| Basic Average Shares | 44,660,518 |
| Diluted Average Shares | 44,660,518 |
| Assets | $9.62M |
| Current Assets | $6.35M |
| Prepaid Expenses | $1.46M |
| Other Current Assets | $4.89M |
| Noncurrent Assets | $3.27M |
| Fixed Assets | $842.00K |
| Other Non-current Assets | $2.43M |
| Liabilities | $3.46M |
| Current Liabilities | $1.76M |
| Noncurrent Liabilities | $1.70M |
| Equity | $6.16M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.16M |
| Liabilities And Equity | $9.62M |
| Net Cash Flow From Operating Activities | -$16.39M |
| Net Cash Flow From Operating Activities, Continuing | -$16.39M |
| Net Cash Flow From Investing Activities | -$262.00K |
| Net Cash Flow From Investing Activities, Continuing | -$262.00K |
| Net Cash Flow From Financing Activities | $7.57M |
| Net Cash Flow From Financing Activities, Continuing | $7.57M |
| Net Cash Flow | -$9.09M |
| Net Cash Flow, Continuing | -$9.09M |
| Comprehensive Income/Loss | -$18.65M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$18.65M |
| Other Comprehensive Income/Loss | $0.00 |